Phase 1/2 Trial to Assess CRISPR Therapeutics’ CAR T Therapy in NMOSD and Related Diseases Rare Disease Advisor 2h
Where Will CRISPR Therapeutics Be in 10 Years if Gene Editing Fulfills Its Promise? The Motley Fool 4d
Gene that drives blood cancer drug resistance uncovered with new CRISPR activation tool ecancer 14h Blood Cancer Cancer Treatment Cancer
Where Will CRISPR Therapeutics Be in 10 Years if Gene Editing Fulfills Its Promise? The Motley Fool 4d CRISPR Therapeutics Biology Biotechnology
Patient-derived tumour organoid biobank maps cancer gene dependencies Drug Target Review 11:36 Wed, 02 Sep Cancer Nature Organoids
What will it take to get new gene editing and RNA breakthroughs to patients? AIChE 15:18 Fri, 11 Sep Chemistry Biology Biotechnology
Weekly reads: Longeveron MSC trial disappoints, CRISPR ancestor Vipr, distinct human brain progenitors, FDA staffing woes The Niche (Weblog) 2d FDA CRISPR/Gene Editing Pharma
Could a daily glass of orange juice support heart health? Study finds citrus compounds influence genes linked to blood vessel function News-Medical.Net 6d Genetics Global Health Science
Antengene publishes preclinical research paper on CD73 small Molecule inhibitor atg-037 combined with selinexor in cancer gene therapy PR Newswire (Press Release) 8d China Politics Biotechnology Biotech
